Cortaid Maximum Strength Cream (Valeant) – Microbial Contamination (2018)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Cortaid Maximum Strength Cream (1% hydrocortisone), 1 OZ (28 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875521011
Brand
Valeant Pharmaceuticals North America LLC
Lot Codes / Batch Numbers
Lot #: 170843B, Exp 2/19, 171484D, Exp 4/19, 171791E, 171848E, Exp 5/19, 172359J, 172360J, 173184J, Exp 9/19, 173512P, Exp 12/19, 180180B, Exp 2/20, 181098C, Exp 3/20
Products Sold
Lot #: 170843B, Exp 2/19; 171484D, Exp 4/19; 171791E, 171848E, Exp 5/19; 172359J, 172360J, 173184J, Exp 9/19; 173512P, Exp 12/19; 180180B, Exp 2/20; 181098C, Exp 3/20
Valeant Pharmaceuticals North America LLC is recalling Cortaid Maximum Strength Cream (1% hydrocortisone), 1 OZ (28 g) tube, OTC, Distributed by: Valeant P due to CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbia. This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA drug enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm, their healthcare provider, or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 7, 2026